Pharmaceuticals ASX Stock News and Announcements

18 November 2024

New!
Clinical trial progress update

Island Pharmaceuticals progresses ISLA-101 trial for dengue fever prevention and treatment.

Island Pharmaceuticals Dengue Fever Clinical Trials Pharmaceuticals Stock Market News

Posted on: 18/11/2024

Read More

14 November 2024

New!
Business to Consumer Commercial Update

ECS Botanics reports robust B2C growth and introduces new 'OzSun' cannabis brand.

ECS Botanics B2C Growth Cannabis Industry Stock Market News

Posted on: 14/11/2024

Read More
New!
Neurizon Presents Positive Preclinical Data on NUZ-001

Neurizon Therapeutics presents positive preclinical data for ALS treatment.

Neurizon Therapeutics ALS Biotechnology Neurodegenerative Diseases Stock Market News

Posted on: 14/11/2024

Read More
New!
NUZ-001 Reduces Aggregation of Key ALS Disease Target

Neurizon's NUZ-001 shows potential in reducing ALS disease target TDP-43 aggregation.

Neurizon Therapeutics ALS Biotech Drug Development Stock Market News

Posted on: 14/11/2024

Read More

13 November 2024

AUD $6.75m R&D Rebate Approved

Recce Pharmaceuticals receives substantial R&D rebate to boost anti-infective research.

Recce Pharmaceuticals R&D Rebate Stock Market News Biotechnology Anti-Infectives

Posted on: 13/11/2024

Read More

4 November 2024

Phase II ABSSSI Clinical Trial Advances to Final Stages

Recce Pharmaceuticals advances Phase II trial for R327G with positive interim results.

Recce Pharmaceuticals R327G Clinical Trials Stock Market News Biotechnology

Posted on: 04/11/2024

Read More

31 October 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Argent BioPharma reports collaboration with SINTEF and voluntary delisting from ASX.

Argent BioPharma Biopharmaceuticals Stock Market News ASX Delisting Corporate Strategy

Posted on: 31/10/2024

Read More
Quarterly Activities/Appendix 4C Cash Flow Report

Argenica reports progress in Phase 2 trial of ARG-007 for stroke treatment.

Argenica Therapeutics Biotechnology Stroke Treatment Clinical Trials Stock Market News

Posted on: 31/10/2024

Read More

17 September 2024

ECS secures exclusive agreement with Terphogz

ECS Botanics will manufacture and sell Terphogz™ cannabis products in Germany, Australia, and New Zealand.

ECS Botanics Terphogz Medicinal Cannabis Stock Market News Cannabis Industry

Posted on: 17/09/2024

Read More

27 August 2024

FY24 Results - Record Harvest, Profit and Revenue

ECS Botanics reports record revenue, profit, and harvest for FY24.

ECS Botanics Financial Results Medicinal Cannabis Stock Market News

Posted on: 27/08/2024

Read More

31 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Argenica Therapeutics advances Phase 2 trial and secures $12 million in funding.

Argenica Therapeutics Clinical Trial Stock Market News Biotechnology Neurology

Posted on: 31/07/2024

Read More

30 July 2024

Quarterly Activities Report

Syntara announces significant progress in clinical trials for myelofibrosis and myelodysplastic syndrome.

Syntara Clinical Trials Myelofibrosis Myelodysplastic Syndrome Stock Market News

Posted on: 30/07/2024

Read More
Quarterly Appendix 4C Cash Flow Report

Syntara Limited reveals significant cash flow details for the quarter ending June 2024.

Syntara Limited Quarterly Cash Flow Stock Market News Financial Report

Posted on: 30/07/2024

Read More
Equity Raising Presentation

Syntara Limited announces a $5 million equity raising for clinical program funding.

Syntara Limited Equity Raising Clinical Trials Stock Market News Biotechnology

Posted on: 30/07/2024

Read More
Placement

Syntara Ltd raises A$5 million to fund Phase 2 clinical trials.

Syntara Ltd Stock Market News Clinical Trials Biotechnology Pharmaceuticals

Posted on: 30/07/2024

Read More

29 July 2024

Corporate Update

Melodiol Global Health secures $1.1 million through equity placement and loans.

Melodiol Global Health Capital Raise Stock Market News Equity Placement Loan Funding

Posted on: 29/07/2024

Read More
Quarterly Activities/Appendix 4C Cash Flow Report

Argent BioPharma lists on OTCQB and appoints new CFO.

Argent BioPharma OTCQB Listing Stock Market News Biopharmaceuticals

Posted on: 29/07/2024

Read More

23 July 2024

Quarterly Activities/Appendix 4C Cash Flow Report

Invex Therapeutics updates on clinical trials, financials, and corporate developments.

Invex Therapeutics Clinical Trials Biopharmaceuticals Stock Market News

Posted on: 23/07/2024

Read More